Tranexamic acid (TXA) may be used to treat skin conditions related to hyperpigmentation (patches of skin darker than the surrounding areas). It is manufactured from lysine (an amino acid) and can ...

ORLANDO -- A hospital policy to increase the use of perioperative tranexamic acid (TXA) reduced blood transfusions during major noncardiac surgeries with no apparent impact on clotting events, a ...

Tranexamic acid (TXA) use is set to widen in England and Wales under new draft guidance from the National Institute for Health and Care Excellence (NICE). NICE recommends offering TXA before any ...

Tranexamic acid is highly efficacious for the treatment of melasma, with optimal outcomes seen through oral administration plus routine topical agents. The efficacy of tranexamic acid alone against ...

This paper is geared toward the Department of Defense medical community, in particular, the U.S. Army Medical Command (USAMEDCOM), and advocates for the widespread adoption of tranexamic acid (TXA) ...

Prophylactic tranexamic acid showed no reduction in blood transfusion rates in open radical cystectomy patients. The trial found no significant differences in secondary outcomes, including estimated ...

Dark spots are one of the trickiest skin concerns to treat because there are so many potential underlying triggers. Exposure to the sun is a common cause of hyperpigmentation, but hormonal changes, ...

The FDA is requiring stronger warnings for tranexamic acid (TXA) injection to avoid medication errors following reports of serious injury, including death. "FDA is ...

A Boxed Warning explaining the risk of medication errors involving inadvertent neuraxial administration will be added to the labeling. The Food and Drug Administration (FDA) has issued an updated ...